Jacobson Pharma Revamps Audit Committee Structure

Jacobson Pharma Corporation Limited (HK:2633) has released an update.

Jacobson Pharma Corporation Limited has revised and adopted new terms for its Audit Committee to enhance financial transparency and internal controls. The committee, composed of a minimum of three non-executive directors, with a majority being independent, will assist the board in financial reporting and risk management. The Audit Committee will meet at least twice annually to review financial statements and engage with external auditors to ensure the integrity of financial practices.

For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.